NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases

Written by Rohan Narayanan on October 27, 2021

October 27, 2021 – The National Institutes of Health, U.S. Food and Drug Administration, 10 pharmaceutical companies and five non-profit organizations have partnered to accelerate development of gene therapies for the 30 million Americans who suffer from a rare disease. While there are approximately 7,000 rare diseases, only two heritable… Read More